MAPT and Alzheimer disease: The study revealed delayed parenchymal clearance of the CSF tracer, particularly in regions such as the hippocampus and entorhinal cortex, which are susceptible to amyloid-beta and tau deposition and are associated with Alzheimer's disease (AD).